Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets
In the proteasome, Rpn2 provides the docking site for substrate receptor Rpn13. Here the authors present the structure of human Rpn13 Pru domain bound to its binding site in Rpn2 and provide insights into the mode of action for Rpn13-targeting molecule RA190, which has anticancer properties.
Guardado en:
Autores principales: | Xiuxiu Lu, Urszula Nowicka, Vinidhra Sridharan, Fen Liu, Leah Randles, David Hymel, Marzena Dyba, Sergey G. Tarasov, Nadya I. Tarasova, Xue Zhi Zhao, Jun Hamazaki, Shigeo Murata, Terrence R. Burke, Jr., Kylie J. Walters |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3558b297c27d4dde9ca8b170d554b63a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors.
por: Ravi K Anchoori, et al.
Publicado: (2021) -
Structure of E3 ligase E6AP with a proteasome-binding site provided by substrate receptor hRpn10
por: Gwen R. Buel, et al.
Publicado: (2020) -
Structure of ubiquitylated-Rpn10 provides insight into its autoregulation mechanism
por: Tal Keren-Kaplan, et al.
Publicado: (2016) -
Rpn11-mediated ubiquitin processing in an ancestral archaeal ubiquitination system
por: Adrian C. D. Fuchs, et al.
Publicado: (2018) -
Application of FEMA and RPN techniques for man-machine analysis in Tobacco Company
por: Bakhtiar Ostadi, et al.
Publicado: (2019)